Vascepa Weekly Script Numbers Is Embarrassing

[anonymous]

Vascepa will face the same fate as Pfizer’s Inhaled Insulin. Truly sad. The expansion of 800 reps was a waste of money.

 

[anonymous]

Maybe what they should have done is launch with territories only have one sales rep per territory instead of two reps per territory.

 

[anonymous]

Vascepa will face the same fate as Pfizer’s Inhaled Insulin. Truly sad. The expansion of 800 reps was a waste of money.

You got that right. What about the cardio/met positions. They are not even working.

 

[anonymous]

Vascepa will face the same fate as Pfizer’s Inhaled Insulin. Truly sad. The expansion of 800 reps was a waste of money.

You don't even work here. You have no idea what it is like on the ground right now. Growth is up year over year already and we are in the middle of deductible and PA resets. Chill out. Go count your stock. Stay off the script boards until March. People were just hired, what would you expect? You must not know how any of this works.

 

[anonymous]

You don't even work here. You have no idea what it is like on the ground right now. Growth is up year over year already and we are in the middle of deductible and PA resets. Chill out. Go count your stock. Stay off the script boards until March. People were just hired, what would you expect? You must not know how any of this works.

Bullshite and you know it! There is absolutely no excuse for the “average” weekly scripts coming through. PIPS need to be handed out left and right. Imagine what the Pfizer or Merck Muscle could do with a Gamechanger like this. A waste of money on this 80” rep expansion!!!!

 

[anonymous]

Bullshite and you know it! There is absolutely no excuse for the “average” weekly scripts coming through. PIPS need to be handed out left and right. Imagine what the Pfizer or Merck Muscle could do with a Gamechanger like this. A waste of money on this 80” rep expansion!!!!

Go F Yourself.

 

[anonymous]

Everyone is tag teaming lunches with their pod partner. It only takes one effective sales person to make a difference, not two. 800 is too many.

 

[anonymous]

Bullshite and you know it! There is absolutely no excuse for the “average” weekly scripts coming through. PIPS need to be handed out left and right. Imagine what the Pfizer or Merck Muscle could do with a Gamechanger like this. A waste of money on this 80” rep expansion!!!!

It's so clear you are a greedy investor wanting a buyout so you can cash in.

 

[anonymous]

Bullshite and you know it! There is absolutely no excuse for the “average” weekly scripts coming through. PIPS need to be handed out left and right. Imagine what the Pfizer or Merck Muscle could do with a Gamechanger like this. A waste of money on this 80” rep expansion!!!!

hey fucker-who the hell do you think you are? Fuck off. You think this drug is an easy sale? Youre a prick who doesnt know anything of what its like in the trenches. Now go back under the fucking rock that you came from. The data isnt that compelling ass lick

 

[anonymous]

The problem isn't the med, it's the company: worst planning ever, no need for more than 200 reps and running around begging signatures is pathetic.

 

[anonymous]

Here’s what’s going on! Patients with diabetes and cardiovascular disease are on many, many medications. Because they refill heavily in December because they have met their deductible, prescriptions in January tend to look lower! Chicken little, the sky isn’t falling!

 

[anonymous]

hey fucker-who the hell do you think you are? Fuck off. You think this drug is an easy sale? Youre a prick who doesnt know anything of what its like in the trenches. Now go back under the fucking rock that you came from. The data isnt that compelling ass lick

This drug IS an easy sell, and if it’s too hard for you to sell then you’re not meant to be in this industry. Or sales in general. Vascepa is probably the easiest sell you’ll have in your career

 

[anonymous]

This drug IS an easy sell, and if it’s too hard for you to sell then you’re not meant to be in this industry. Or sales in general. Vascepa is probably the easiest sell you’ll have in your career

I agree with this. Managed care is what makes it hard. If ever script written actually converted to a fill for a patient, we would not even be having this conversation. Its getting switched and PA'd left and right. Fix the managed care and it takes off.

 

[anonymous]

I agree with this. Managed care is what makes it hard. If ever script written actually converted to a fill for a patient, we would not even be having this conversation. Its getting switched and PA'd left and right. Fix the managed care and it takes off.

All these excuses! I hope Upper Management reads this. These are the people hired to take this drug to 5B per year?! This is precisely why Big Pharma needs this drug in their hands to benefit Humanity immediately!

 

[anonymous]

All these excuses! I hope Upper Management reads this. These are the people hired to take this drug to 5B per year?! This is precisely why Big Pharma needs this drug in their hands to benefit Humanity immediately!

So you blame us if a patient walks away because they cannot afford it or if their plan makes them fail another therapy first?

 

[anonymous]

Managed care is where it is at! Managed care only worked in those regions of the country where they had sales reps.. We are trying to sell a med that has no coverage (previous white space). The company should have anticipated having the sNDA and had managed care work in high potential white space in late 2018 and early 2019! Pretty hard to sell when all drugs on formulary are generics!

 

[anonymous]

Wondering how much experience current posters have with launches in post ACA world. Commercial plans have much greater flexibility for formulary changes in real time. Most Medicare plans adjust plans once per year and that tends to be later in the calendar year with changes taking place Jan 1 of the next year. Even aggressive managed care contracting rarely gets access above 50% in the first 12 months. 65 to 75% access(combined Commercial and Medicare) typically take at least 18 months. Appropriate understanding of this process can reduce stress and frustration, freeing you up to help the patients you can while the slow wheels of Medicare turn. ( I don't work for Amarin, no axe to grind). Best of luck to you all.

 

[anonymous]

Managed care is where it is at! Managed care only worked in those regions of the country where they had sales reps.. We are trying to sell a med that has no coverage (previous white space). The company should have anticipated having the sNDA and had managed care work in high potential white space in late 2018 and early 2019! Pretty hard to sell when all drugs on formulary are generics!

Understand your frustration, look at the timing of the trial and FDA indication. If the indication come after Medicare plans have negotiated and set their formularies for the next year, there is nothing to be done until the next formulary window. I know it is madding...but this is true regardless of company of its management .

 

[anonymous]

Something to remember as well is that pharmacists at many of your large chains are incentivized to write generics. So if there is a generic alternative to your branded drug, guess what is going to happen? Docs are incentivized as well by major practices that contract with insurance companies. It’s amazing when a branded drug is written in these times.

 

[anonymous]

hey fucker-who the hell do you think you are? Fuck off. You think this drug is an easy sale? Youre a prick who doesnt know anything of what its like in the trenches. Now go back under the fucking rock that you came from. The data isnt that compelling ass lick

The data isn’t that compelling?? You’re a stupid f_ck that doesn’t know Jack! It’s VERY compelling! Get off our board!